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http://www.molecularpain.com/content/10/1/2RESEARCH Open AccessAcid evoked thermal hyperalgesia involves
peripheral P2Y1 receptor mediated TRPV1
phosphorylation in a rodent model of thrombus
induced ischemic pain
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Background: We previously developed a thrombus-induced ischemic pain (TIIP) animal model, which was characterized
by chronic bilateral mechanical allodynia without thermal hyperalgesia (TH). On the other hand we had shown
that intraplantar injection of acidic saline facilitated ATP-induced pain, which did result in the induction of TH in
normal rats. Because acidic pH and increased ATP are closely associated with ischemic conditions, this study is
designed to: (1) examine whether acidic saline injection into the hind paw causes the development of TH in TIIP,
but not control, animals; and (2) determine which peripheral mechanisms are involved in the development of
this TH.
Results: Repeated intraplantar injection of pH 4.0 saline, but not pH 5.5 and 7.0 saline, for 3 days following TIIP
surgery resulted in the development of TH. After pH 4.0 saline injections, protein levels of hypoxia inducible
factor-1α (HIF-1α) and carbonic anhydrase II (CA II) were elevated in the plantar muscle indicating that acidic
stimulation intensified ischemic insults with decreased tissue acidity. At the same time point, there were no
changes in the expression of TRPV1 in hind paw skin, whereas a significant increase in TRPV1 phosphorylation
(pTRPV1) was shown in acidic saline (pH 4.0) injected TIIP (AS-TIIP) animals. Moreover, intraplantar injection of
chelerythrine (a PKC inhibitor) and AMG9810 (a TRPV1 antagonist) effectively alleviated the established TH. In
order to investigate which proton- or ATP-sensing receptors contributed to the development of TH, amiloride
(an ASICs blocker), AMG9810, TNP-ATP (a P2Xs antagonist) or MRS2179 (a P2Y1 antagonist) were pre-injected
before the pH 4.0 saline. Only MRS2179 significantly prevented the induction of TH, and the increased pTRPV1
ratio was also blocked in MRS2179 injected animals.
Conclusion: Collectively these data show that maintenance of an acidic environment in the ischemic hind paw
of TIIP rats results in the phosphorylation of TRPV1 receptors via a PKC-dependent pathway, which leads to the
development of TH mimicking what occurs in chronic ischemic patients with severe acidosis. More importantly,
peripheral P2Y1 receptors play a pivotal role in this process, suggesting a novel peripheral mechanism underlying the
development of TH in these patients.
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During pathological conditions such as ischemia, inflam-
mation and tissue injury, a huge array of endogenous che-
micals are released into the tissue that contribute to
sensory phenomena including pain and hyperalgesia. These
endogenous pain producing and sensitizing substances ac-
tivate nociceptive nerve endings by binding to receptor
molecules on their surface. Increasing evidence indicates
that different sets of molecules contribute to mechanical
and thermal hypersensitivity via several mechanisms in
peripheral tissue [1-4]. A representative molecule is
TRPV1, which is a noxious heat stimulus sensor and
its activation results in a decreased threshold for heat
stimuli [5-7]. It is well recognized that activation of
TRPV1 receptors by various pro-algesic substances such
as protons, ATP, bradykinin and prostaglandins contribute
to peripheral sensitization, particularly to heat stimuli dur-
ing the pathological states [1,5].
Ischemic pain typically results from a shortage of
blood supply to tissue and is associated with a number
of pathological states including atherosclerosis and inter-
mittent claudication resulting from peripheral arterial
disease (PAD) [8,9]. Intermittent claudication is a type of
muscle pain which occurs during ambulation, and this is
an early symptom in PAD patients [10]. As the disease
progresses, severe limb ischemia might result in pain at
rest without exercise [10]. Although patients with PAD
demonstrate a range of ischemic pain severity, with abnor-
mal response to mechanical and heat stimulus [9,11,12],
mechanistic differences in pain intensity and modality
have been poorly explored. Since there were no proper
animal models that mimic the mechanisms of peripheral
ischemia observed in PAD patients, we previously devel-
oped and described a new animal model of thrombus-
induced ischemic pain (TIIP) in the rat and investigated
the peripheral mechanisms underlying this ischemia in-
duced pain [13,14]. TIIP rats showed persistent bilateral
mechanical allodynia and we demonstrated that peripheral
acid-sensing ion channels (ASICs) and P2X receptors
were involved in the maintenance of this thrombus-
induced ischemic pain [14]. These results indicated that
protons associated with low ischemic pH and an increased
concentration of ATP at the ischemic site played crucial
roles in the development of ischemia-induced peripheral
sensitization.
Thermal hyperalgesia (TH) has been shown to develop
in chronic ischemic patients with severe acidosis and
thus we would anticipate that it should be present in the
TIIP model. While ischemia-induced conditions are closely
associated with TRPV1 activation [15-19], and TRPV1 is
the endpoint target of a variety of sensitizing substances in-
cluding protons and ATP [1,5,6], TIIP rats show no hyper-
sensitivity to heat stimuli, i.e. thermal hyperalgesia (TH),
and changes in the pharmacological activity of peripheralTRPV1 is not detected in this model [13,14]. These find-
ings suggest that the lack of TH development in TIIP
animals might be caused by the internal ischemic en-
vironment, such that the acidity and the ATP concen-
tration are inadequate to activate TRPV1. Previously,
we have demonstrated a facilitatory effect of acidic pH
on ATP-induced hypersensitivity in the normal rat’s
hind paw utilizing α,βme-ATP as a substitute for en-
dogenous ATP [20]. Although injection of acidic pH or
α,βme-ATP alone failed to activate TRPV1 and P2Y1
receptors and produce TH, a combination of acidic pH
in the presence of α,βme-ATP, did induce a transient
TH via the activation of peripheral P2Y1 and TRPV1
receptors [20]; these results suggested that the syner-
gistic action of acidic pH and ATP directly or indir-
ectly activated TRPV1 and P2Y1 receptors. However,
the interrelationship between these receptors and the
potential molecular mechanisms underlying the devel-
opment of TH under ischemic conditions is unclear. In
the present study we used the TIIP animal model to in-
vestigate the peripheral induction mechanisms of TH
shown in chronic ischemic patients with severe acid-
osis. In this regard, the present study examines: (1)
whether injection of acidic saline into the hind paw
causes the development of TH and changes the local
tissue ischemic and acidic conditions in TIIP rats; (2)
which proton and ATP sensing receptors are involved
in this newly developed TH; and finally (3) whether




Sprague–Dawley rats (weighing 350 to 400 g) were ob-
tained from the Laboratory Animal Center of Seoul
National University (SNU). All experimental procedures
were approved by the SNU Animal care and Use Commit-
tee and performed according to guidelines established by
NIH (NIH Revised Guide for the Care and Use of Labora-
tory Animals; eighth edition, National Academies Press,
2011). Animals were housed in a standard animal facility
maintained in a 12 h light/dark cycle and a constant room
temperature (maintained between 20–25°C) with 40–60%
humidity. Food and water were available ad libitum
throughout the investigation.
TIIP surgery
TIIP surgery was performed according to the method
described by Seo et al. [13]. Briefly, rats were first anes-
thetized intraperitoneally with a Zoletil 50® (Virbac la-
boratories, 06516 Carros) and Rompun® (Bayer Korea
Ltd, Ansan) mixture (combining 2.5 mg of Zoletil 50®
with 0.47 mg of Rompun® in saline), and then a small in-
cision was made in the femoral triangle of the left
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femoral vein and nerve by a piece of moisture-resistant
film (Parafilm®, Chicago, IL, USA, 1 × 2.5 cm) to prevent
possible ferrous chloride damage to these structures. A
filter paper disc (0.5 × 0.5 cm; No. 2, Toyo Roshi Kaisha,
Ltd., Japan) soaked with 20% FeCl2 (FeCl2 · 4H2O, Sigma,
St. Louis, MO, USA) solution was placed on the femoral
artery for 20 minutes. After the incision was surgically
closed and covered by surgical dressing, animals were
kept in a warming chamber (28°C) until they completely
recovered from the anesthesia.
Intraplantar drug administration and experimental
procedures
After rats were briefly anesthetized with Gerolan®, inhal-
ation anesthetic (Choong-wae, Hwa-seong, Kyonggi, Korea)
in an acylic chamber, 30 μl of each drug or 50 μl of acidic
saline was injected into the central sole region of the hind
paw. The pH was adjusted with 1 N HCl solution [20,21].
In order to provide a more acidic environment to the ische-
mic hind paw, pH 4.0 saline was injected intraplantarly
once daily from day 0 to 3 following TIIP surgery (acidic
saline injected TIIP, AS-TIIP). The first injection of pH 4.0
saline was performed immediately after the surgery (day 0),
and nociceptive behavioral testing was started beginning on
day 1 post-surgery. Acid-induced thermal hyperalgesia
(TH) was measured in two parts. The long-term effects
of acid-induced TH were evaluated at days 1, 2, 3, 5, 7
and 12 after TIIP surgery. In order to avoid possible
acute effects of acidic stimulation, during our examin-
ation of the long-term effects of acidic saline, we first
examined TH beginning 2 hours after pH 4.0 saline in-
jections (Figure 1A). In attempt to examine the pos-
sible short-term effects of acidic saline, we measured
withdrawal response latency (sec) to heat over a 12-hour
period following pH 4.0 injection on days 1 and 3 post-
surgery. In this set of experiments we analyzed behavioral
changes at 30 min, 1, 2, 4, 8 and 12 hours following the in-
jection of pH 4.0 saline.
AMG9810 (a TRPV1 antagonist), chelerythrine (a PKC
inhibitor), Amiloride (an ASICs blocker), TNP-ATP (a P2X
receptor antagonist), or MRS2179 (a P2Y1 receptor antag-
onist) was injected into the hind paw in order to investigate
the mechanisms underlying the development of thermal
hyperalgesia (TH). The potential involvement of TRPV1
and PKC dependent pathways during the maintenance
phase of TH was evaluated by a single injection of
AMG9810 and chelerythrine at day 3 post-surgery. To fur-
ther explore the intrinsic mechanisms underlying the de-
velopment of TH, Amiloride, AMG9810, TNP-ATP and/or
MRS2179 were repeatedly injected once a day (D0-D3 after
surgery) 30 min before the acidic saline injection. Each
control group received an intraplantar injection of the ap-
propriate vehicle for each drug. Animals were randomlyassigned to experimental groups and subsequent drug
treatment and behavioral analyses were performed blindly.
Assessment of thermal hyperalgesia
To assess nociceptive responses to noxious heat stimuli,
we measured the paw withdrawal response latency (PWL)
using a plantar test apparatus (Series 8, Model 390, IITC
Life Science Inc., Woodland Hills, CA, USA), and evalu-
ated animal’s sensitivity to noxious heat stimulation (ther-
mal hyperalgesia). Before the test, rats were placed in a
plastic chamber with a glass floor and allowed to accli-
mate for 15 minutes. Room temperature was constantly
maintained between 26–28°C. A radiant heat source was
positioned under the glass floor beneath the hind paw to
be tested and withdrawal latency was measured by using a
photoelectric cell connected to a digital clock. Baseline la-
tency responses (10–15 sec) were determined before ex-
perimental treatment. The test was repeated in each hind
paw at each time point and the mean withdrawal latency
was calculated. A cut-off time of 20 seconds was used to
protect the animal from excessive tissue damage.
Resiniferatoxin treatment
In order to examine the possible role of TRPV1 con-
taining peripheral nerve fibers, we treated the animals
with the potent capsaicin analog, Resiniferatoxin (RTX,
0.3 mg/kg; Sigma, St. Louis, MO) dissolved in a mix-
ture of 10% Tween 80, 10% ethanol, 80% normal saline
[22]. After rats were anesthetized with 3% isoflurane in
a mixture of N2O/O2 gas, either RTX or vehicle was
injected subcutaneously in a volume of 0.2 ml into the
scruff of the neck. The eye wipe reflex test was subse-
quently performed to check whether RTX treatment
destroyed capsaicin sensitive primary afferent fibers at
day 2 post-RTX injection. A diluted capsaicin solution
(0.01%, dissolved in saline) was dropped onto cornea,
and then the number and the duration of eye wipes
were counted for 1 min. Following the eye wipe reflex
test, we performed sham and TIIP surgery in vehicle-
treated animals and in RTX-treated animals that showed
no response to diluted capsaicin solution.
Western blot analysis
Plantar muscle and skin from the ipsilateral hind paw
were collected from anesthetized rats at postoperative
day 3; to avoid acute effects of adjusted saline injection,
we obtain tissue samples for western blot analysis at
least 2 hours after saline injections. The tissue were ho-
mogenized in buffer containing 1 M Tris (pH 7.5), 1%
NP-40, 0.5 M EDTA (pH 7.5), 50 mM EGTA, 1 M di-
thiothreitol, 1 M benzanidine and 0.1 M PMSF. The
total amount of protein in each sample was determined
using the Bradford dye assay prior to loading on poly-
acrylamide gels. The tissue homogenates (30 μg protein)
Figure 1 Thermal hyperalgesia (TH) caused by intraplantar injection of acid in thrombus-induced ischemic pain (TIIP) rats. (A) Long-term
effects of acid (D0-3 post-surgery) induced TH in TIIP rats. We evaluated TH of sham control rats (pH 7.0 and 4.0, n = 7 and 5 in each group) and TIIP
rats (pH 7.0, 5.5 and 4.0, n = 5, 5 and 9 in each group) at day 1, 2, 3, 5, 7 and 12 after the surgery. TH was measured 2 hours after saline injection to
avoid its acute effects. Only in the TIIP + pH 4.0 saline (acidic saline injected TIIP, AS-TIIP) group, did significant TH develop beginning on day 1 after
the injection of pH 4.0 saline and continuing for the duration of the injection period (**P < 0.01, ***P < 0.001 vs sham+pH 7.0 saline). (B) Short-term effects
of acid-induced TH in TIIP rats at day 1 post-surgery. We evaluated TH in sham and TIIP rats following injection of pH 4.0 saline (n = 6 in each group) at
30 min, 1, 2, 4, 8 and 12 hours after pH 4.0 saline injection. After pH 4.0 saline injection, AS-TIIP rats showed prominent TH compared to sham rats; TH was
observed from 30 min to 8 hours post-injection (*P < 0.05, **P < 0.01 and ***P < 0.005 vs sham + pH 4.0 saline). (C) Short-term effects of
acid-induced TH in TIIP rats at day 3 post-surgery. We evaluated TH in sham and TIIP rats following injection of pH 4.0 (n = 6 in each group)
at 30 min, 1, 2, 4, 8 and 12 hours after pH acid injection. Significant TH was present in AS-TIIP rats prior to pH 4.0 saline injections. Following pH
4.0 saline injections, AS-TIIP rats showed sustained TH, which did not recover until 12 hours post-injection (**P < 0.01, ***P < 0.001 vs sham+pH 4.0 saline).
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phoresis and transferred to nitrocellulose. After the blots
had been washed with TBST [10 mM Tris–HCl (pH 7.6),
150 mM NaCl, 0.05% Tween-20], the membranes were
blocked with 5% skim milk for 1 hour. The muscle sam-
ples were incubated with primary antibodies for hypoxia
inducible factor-1α (HIF-1α, 1:1000) or carbonic anhy-
drase II (CA II, 1:1000), which were purchased from the
Santa Cruz Biotechnology (Delaware, CA). We utilized a
TRPV1 polyclonal antibody (1:1000, Santa Cruz Biotech-
nology Inc., Santa Cruz, California, USA) and a pTRPV1
(phosphor S800) polyclonal antibody (1:1000, Abnova
corporation, Taipei City, Taiwan) for skin samples. β-actin
antibody was used as a loading control (Sigma, St. Louis,
MO). After the secondary antibody reaction, the
bands were visualized with enhanced chemilumines-
cence (Amersham Pharmacia Biotech, England, UK).
The positive pixel area of specific bands was measured
with a computer-assisted image analysis system (Meta-
morph®, version 6.3r2, Molecular Devices Corporation,
PA) and normalized against the corresponding β-actin
loading control bands. Then the ratio of pTRPV1 /TRPV1
expression was calculated. The mean values of the TRPV1
and pTRPV1/TRPV1 positive pixel area in the sham
group was set at 100% and used for comparison with the
experimental group.
Immunohistochemistry
Animals were deeply anesthetized with an intra-peritoneal
injection of a Zoletil-Rompun-saline mixture (2:1:2). Ani-
mals were perfused transcardially with calcium-free
Tyrode’s solution, followed by a fixative containing 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4).
The ipsilateral DRGs (L4-L5) were collected after per-
fusion, post-fixed in the identical fixative for 4 hours
and then placed in 30% sucrose in PBS (pH 7.4) at 4°C
overnight. Frozen serial frontal sections (10 μm) were
cut through the DRG L4–L5 using a cryostat (Microm,
Walldorf, Germany). These serial sections were pre-
blocked with 3% normal donkey serum and 0.3% Triton
X-100 in PBS for 1 hour at room temperature. Tissue sec-
tions were incubated at 4°C with goat polyclonal TRPV1
antibody (1:250, Santa Cruz Biotechnology Inc., Santa
Cruz, California, USA) for 48 h and followed by Alexa-
Fluor 488 conjugated secondary antibody (1:500, invi-




arboxamide hydrochloride (Amiloride), (2E)-N-(2,3-Dihy-
dro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-
2-propenamide (AMG9810), Chelerythrine, 2′,3′–O–(2,4,
6-Trinitrophenyl)adenosine-5′-triphosphate triethylammoniumsalt (TNP-ATP), 2′-Deoxy-N6-methyladenosine 3′,5′-
bisphosphate tetrasodium salt (MRS2179) and [[(1R,
2R,3S,4R,5S)-4-[6-Amino-2-(methylthio)-9H-purin-9-
yl]-2,3-dihydroxybicyclo[3.1.0]hex-1-yl]methyl] diphospho-
ric acid mono ester trisodium salt (MRS2365) were
purchased from Tocris (Ellisville, MO, USA). Amiloride,
TNP-ATP, MRS2179 were dissolved in saline, respectively.
AMG9810 was dissolved in 10% ethyl alcohol. Chelerythr-
ine was dissolved in 5% DMSO. A 30 μl volume of one of
the above drugs was injected intraplantarly for individual
experiments.
Statistical analysis
Statistical analysis was performed using Prism 5.1 (GraphPad
Software, San Diego, CA). One-way analysis of variance
(ANOVA) was performed to determine the change in
TRPV1 and pTRPV1/TRPV1 concentrations in the ischemic
hind paw skin. For posthoc analysis, the Newman-Keuls
multiple comparison test was subsequently performed to de-
termine significant differences among groups. A value
of P < 0.05 was considered to be statistically significant.
Behavioral data were tested using a two-way ANOVA
to determine the overall effect of the drugs in each
time-course.
Results
Long-term effects of intraplantar acidic saline injection on
thermal hyperalgesia (TH) in TIIP rats
We injected pH adjusted saline solution (pH 4.0, 5.5, or
7.0) into the hind paw of TIIP rats once per day from
days 0 to 3 after TIIP surgery to determine the potential
effect of a more acidic, ischemic environment on ther-
mal nociception. Repeated injection of pH 4.0 saline
(Days 0 to 3 after surgery) caused a significant reduction
in paw withdrawal latency to thermal stimuli in TIIP rats
(Figure 1A). In order to investigate long-term effects of
acid induced changes in heat hypersensitivity, we mea-
sured TH at day 1, 2, 3, 5, 7 and 12 after the surgery.
The threshold for heat stimulation was evaluated at 2
hours post-injection in order to avoid potential acute
effects of the pH 4.0 saline solution. TH developed on
day 1 post-injection following TIIP surgery and was
maintained throughout the entire 3-day injection period
(Figure 1A; **P < 0.01, ***P < 0.005 vs sham+ pH 7.0 sa-
line), and gradually recovered over a period of several days
after the injection period ended (Figure 1A). By contrast,
the thermal threshold was unchanged in TIIP rats injected
intraplantarly with pH 7.0 saline in the ipsilateral paw and
thus, TH never developed. Importantly the two control
groups (sham rats injected daily with pH 4.0 or pH 7.0 sa-
line solutions) did not develop TH (Figure 1A) indicating
that the ischemic condition was necessary for this acidic-
induced TH to develop. Furthermore, one group of TIIP
rats was injected into the ischemic hind paw with pH 5.5
Figure 2 Western blot analysis of hypoxia inducible factor-1α
(HIF-1α) and carbonic anhydrase II (CA II). HIF-1α (n = 5 in each
group, day 3 post pH 4.0 saline injection) and, CA II (n = 4 in each
group, day 3 post pH 4.0 saline injection) were quantitatively evalu-
ated in sham and ischemic hind paw muscle lysates by western
blotting. (A) The protein concentration of HIF-1α was significantly
increased in the pH 7.0-treated thrombus induced ischemic pain
(TIIP) group, and the protein concentration of HIF-1α was increased to
an even greater extent in the pH 4.0 saline injected TIIP group (AS-TIIP);
(*P < 0.05, **P < 0.01 vs sham+ pH 7.0 saline). (B) The protein level of
CA II was also significantly increased in pH 7.0-treated TIIP and AS-TIIP
groups compared to the pH 7.0-treated sham group. pH 4.0 saline
injection induced an additional increase in CA II expression in the AS-TIIP
group compared to the pH 7.0-treated TIIP group. (*P< 0.05, **P< 0.01
vs sham+ pH 7.0 saline and #P< 0.05 vs TIIP + pH 7.0 saline). Data are
presented as percentage of change (%) relative to sham control. β-actin
was used as a loading control.
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pH 5.5 saline solution did not significantly decrease the
threshold for the thermal stimulus (Figure 1A). Since only
pH 4.0 saline induced the behavioral changes in thermal
hypersensitivity in TIIP rats, we injected pH 4.0 saline into
the ischemic hind paw in the remaining experiments as
outlined below.
Short-term effects of intraplantar acidic saline injection
on thermal hyperalgesia (TH) in TIIP rats
In addition to the long-term changes in acid induced
TH in TIIP rats, we observed changes in the time course
of behavioral responses induced by a single injection of
acidic saline (at days 1 and 3 post-surgery). After pH 4.0
injection, we observed changes in the withdrawal re-
sponse latency (sec) at 30 min, 1, 2, 4, 8 and 12 hours
post-injection (Figure 1B, 1C). On day 1, TIIP rats showed
no significant TH prior to pH 4.0 injection compared to
sham+ pH 4.0 rats (Figure 1B). Following pH 4.0 saline
injections, TIIP rats developed a significant TH compared
to sham rats; TH was observed from 30 min to 8 hours
post-injection. This thermal hyperalgesia slowly decreased
beginning at 8 hours post-injection and the animals
showed normal thermal responses by 12 hours after injec-
tion (Figure 1B; *P < 0.05, **P < 0.01 and ***P < 0.005
vs sham + pH 4.0 saline). At day 3 post-surgery, sig-
nificant TH was already present in acidic saline injected
TIIP (AS-TIIP) rats before pH 4.0 saline injection
(Figure 1C; **P < 0.01 vs sham+ pH 4.0 saline). Moreover,
after pH 4.0 injections, AS-TIIP rats showed persistent
TH and did not recover until 12 hours post-injection
(Figure 1C; **P < 0.01 and ***P < 0.005 vs sham +
pH 4.0 saline). Collectively, the TH induced by a single
acidic saline injection was transient at day 1; however,
following 2 more acidic saline injections, the TIIP rats
developed persistent thermal hypersensitivity which
was maintained for 2 days following the cessation of
acidic saline injection (until day 5 post-surgery).
Injection of acidic saline results in an increase in hypoxic
status and acidity of the ischemic hind paw
In order to evaluate whether repeated pH 4.0 saline in-
jection induced changes in hypoxic status and acidity of
peripheral hind paw tissue, hind paw muscle samples
were collected at 3 days post-surgery following three
days of acidic saline injection. To avoid potential acute
effects of pH 4.0 and 7.0 saline injection, we euthanized
the animals at least 2 hours post-injection. Since hypoxia
inducible factor-1α (HIF-1α) is a well-known index of
hypoxia and carbonic anhydrase II (CA II) has been re-
ported to be a major indicator of pH imbalance [23-29],
we examined changes in these two factors by western
blot analysis (Figure 2). The protein concentration of
HIF-1α was significantly increased in pH 7.0-treatedTIIP rats, but there was a larger increase in acidic sa-
line (pH 4.0) injected TIIP (AS-TIIP) rats (Figure 2A;
*P < 0.05, **P < 0.01 vs sham + pH 7.0 saline). The pro-
tein concentration of CA II was also significantly in-
creased in both the pH 7.0-treated TIIP and acidic saline
(pH 4.0) injected TIIP animals compared to the pH 7.0-
treated sham group (Figure 2B). The additional acidic sa-
line injection resulted in significant increase in CA II
expression in the AS-TIIP group compared to the pH 7.0-
treated TIIP group (Figure 2B; *P < 0.05, **P < 0.01 vs
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line). As a control group, we tested sham rats repeatedly
injected with pH 4.0 saline, and there were no significant
changes in either HIF-1α or CA II expression.
TRPV1 and phosphorylated TRPV1 expression of hind
paw lysates in acidic saline injected TIIP (AS-TIIP) rats
Since peripheral TRPV1 receptors were considered to be
pivotal thermal sensors that contribute to the develop-
ment of thermal hypersensitivity, we investigated pos-
sible changes in TRPV1 expression and phosphorylation
rate in skin from the ischemic hind paw. To address this,
we performed a western blot analysis of both TRPV1
and phosphorylated TRPV1 (pTRPV1) to determine
whether peripheral ischemia alone or coupled with in-
creased tissue acidity (induced by pH 4.0 saline injection)
caused a change in TRPV1 expression and phosphoryl-
ation in paw lysates (Figure 3) at postoperative day 3 fol-
lowing three days of acidic saline injection. Expression of
peripheral TRPV1 receptors was not significantly changed
in pH 7.0-treated TIIP rats or in the acidic saline injected
TIIP (AS-TIIP) group (Figure 3A). No statistical differ-
ences were detected among any of the 4 conditions at this
time point. Quantitative analysis of TRPV1 expression
was normalized against corresponding β-actin. TRPV1
has two phosphorylation sites for PKC-mediated phos-
phorylation: S502 and S800 [5]. The pTRPV1 antibody
used in this study reacted with pTRPV1 at S800. Injection
of acidic saline significantly increased the ratio of
pTRPV1/TRPV1 and this was positively correlated with
the induction of TH (Figure 3B; **P < 0.01 vs sham+
pH 7.0 saline). Quantitative analysis of pTRPV1 expres-
sion was normalized against corresponding total TRPV1
expression.
TRPV1 and phosphorylated TRPV1 expression of hind
paw lysates in acidic saline injected TIIP (AS-TIIP) rats
with resiniferatoxin (RTX) treatment
Since TRPV1 is highly expressed in epidermal nerve fi-
bers as well as in keratinocytes distributed in the epider-
mis of the skin [30-33], we perform an additional set of
experiments to determine whether ischemic conditions
result in the phosphorylation of TRPV1 receptors lo-
cated in nerve terminals and/or epidermal keratinocytes.
We treated separate groups of rats with the potent cap-
saicin analog Resiniferatoxin (RTX) two days before TIIP
surgery to abolish capsaicin sensitive sensory neurons.
Following RTX treatment, AS-TIIP rats did not show
significant thermal hypersensitivity at day 3 (Figure 4B),
and there were no detectable TRPV1 positive cells in
lumbosacral DRGs indicating that TRPV1 positive
neurons were completely abolished in these ganglia
(Figure 4A). However, after RTX treatment, TRPV1
and pTRPV1 were still detected with western blotting;indicating that a significant portion of TRPV1 was
found in non-neuronal sources compared to that in
nerve endings (Figure 4C, 4D). Interestingly, although
a large amount of TRPV1 still existed in RTX treated
rats, there were no significant changes in pTRPV1/
TRPV1 levels in AS-TIIP rats (Figure 4D). These re-
sults suggest that TRPV1 from non-neuronal cells does
not contribute substantially to TH and that the up-
regulation in pTRPV1 occurs predominantly in periph-
eral nerve fibers rather than keratinocytes.
The involvement of TRPV1 and PKC dependent pathways
in the maintenance of thermal hyperalgeisa (TH) in acidic
saline injected TIIP (AS-TIIP) rats
To investigate the involvement of TRPV1 and PKC
dependent signaling in this acid induced TH, the se-
lective TRPV1 antagonist (AMG9810) or the PKC in-
hibitor (chelerythrine) were injected into the hind paw
of AS-TIIP rats at day 3 post-surgery following daily
pH 4.0 saline injection. (Figure 5). Following injection
of AMG9810 (Figure 5A) or chelerythrine (Figure 5B)
into the hind paw that had established TH, we examined
possible behavioral changes in thermal hypersensitivity for
3 hours post-injection. Both AMG9010 (3 and 10 nmol)
and Chelerythrine (10 and 30 nmol) dose-dependently re-
versed the established TH induced by acidic saline injec-
tion in TIIP rats. AMG9810 significantly reversed TH at
30 min and 1 h after injection, and chelerythrine in-
hibited TH at 1 h and 3 h after injection (Figure 5;
*P < 0.05, **P < 0.01 and ***p < 0.001 vs vehicle).
The involvement of proton sensing ion channels and P2
receptors in the induction of thermal hyperalgesia (TH) in
acidic saline injected TIIP (AS-TIIP) rats
To examine the potential role(s) of proton sensing ion
channels and P2 receptors in the development of TH in
the ischemic hind paw, we investigated the pharmaco-
logical effects of ASIC blockers and TRPV1, P2X and
P2Y1 antagonists on TH in AS-TIIP rats. The potential
role of proton-sensing receptors in the development of
TH was evaluated first. To do this, rats were initially
injected intraplantarly with either amiloride or AMG9810
daily 30 min before the pH 4.0 saline injections (Figure 6A,
6B, from days 0 to 3 after surgery). Both amiloride and
AMG9810 were ineffective in preventing the development
of TH in AS-TIIP rats (Figure 6A, 6B). It is interesting to
note that the TRPV1 antagonist, AMG9810 fails to block
the development of TH even though TRPV1 receptors ap-
pear to be involved in maintaining the lowered threshold
for a noxious heat stimulus (Figures 5A and 6B). We next
evaluated whether P2 receptors were involved in the de-
velopment of TH caused by acidic saline injection under
ischemic conditions (Figure 6C, 6D). To elucidate which
P2 receptor subtype (P2X or P2Y1) contributed to induce
Figure 3 Western blot analysis of TRPV1 and phosphorylated TRPV1 (pTRPV1) expression. (A) TRPV1 receptor expression in hind paw skin
lysates was quantitatively evaluated in sham + pH 7.0 saline, sham + pH 4.0, thrombus-induced ischemic pain (TIIP) + pH 7.0 saline, acidic saline
(pH 4.0) injected TIIP (AS-TIIP) by western blotting. The protein expression of TRPV1 did not change in pH 7.0-treated TIIP and AS- TIIP rat groups
compared to 7.0-treated sham groups (n = 4 in each group, 3 days after surgery and pH 4.0 injection). Each band was normalized against the
corresponding β-actin band used as loading control. (B) We detected PKC dependent pTRPV1 using western blotting in the hind paw skin
of sham + pH 7.0 saline, sham + pH 4.0 saline, TIIP + pH 7.0 saline and AS-TIIP (n = 4 in each group, 3 days after surgery and pH 4.0 saline injections).
The expression of pTRPV levels significantly increased in AS-TIIP rats (**p < 0.01 vs sham+pH 7.0 saline) but not in pH 4.0 treated sham and pH 7.0-treated
TIIP rats. The pTRPV1 level was normalized against corresponding total TRPV1. Data are presented here as a percentage change (%) compared to the
sham control.
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with a potent P2X antagonist, TNP-ATP (100 and 300 mol)
or a selective P2Y1 antagonist, MRS2179 (100 and
300 nmol). Animals were pretreated with TNP-ATP
or MRS2179 daily 30 min before the 4.0 saline injec-
tion (Figure 6C, 6D, from day 0 to 3). MRS2179 (100
and 300 nmol) dose-dependently blocked the develop-
ment of TH, while TNP-ATP did not affect the onset of
TH (Figure 6D *P < 0.05, **P < 0.01 vs vehicle).Peripheral P2Y1 receptors modulate TRPV1 activity by
PKC-dependent phosphorylation in acidic saline injected
TIIP (AS-TIIP) rats
Since P2Y1 receptors appeared to play a crucial role in
acidic saline induced TH in TIIP rats (Figure 6D), an
additional experiment was performed to test the hypoth-
esis that P2Y1 receptors might modulate TRPV1 activity
under ischemic conditions. To address this, we performed
a western blot analysis of phosphorylated TRPV1
Figure 4 (See legend on next page.)
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Figure 4 The effect of acid in thermal hyperalgesia (TH) and TRPV1 expression in Resiniferatoxin (RTX) treated rats. (A)
Immunofluorescent images of rat DRG neurons. Thin sections (10 μm) of rat DRGs (L4-L5) were stained with antibodies against TRPV1 in the
vehicle and RTX treated groups. The TRPV1-immunostaining in DRG neurons were almost completely abolished in RTX treated rats. Images are
shown at 200× magnification. Scale bars represent 100 μm. (B) Short-term effects of acid induced TH in RTX treated TIIP rats at day 3. We evaluated
the development of TH in RTX treated sham+ pH 4.0 and acidic saline (pH 4.0) injected TIIP (AS-TIIP) rats (n = 4 in each group) at 30 min, 1, 2, 4, 8 and
12 hours after saline injection. RTX treated rats did not show TH following TIIP surgery and pH 4.0 injection. (C) TRPV1 receptor expression in hind paw
skin lysates was quantitatively evaluated in RTX treated groups including sham+ pH 7.0 saline, sham + pH 4.0 saline, TIIP + pH 7.0 saline and AS-TIIP by
western blotting. The protein expression of TRPV1 did not change in any of the RTX treated groups compared to 7.0-treated sham groups (n = 6 in
each group, 3 days after surgery and pH 4.0 injection). Each band was normalized against the corresponding β-actin band used as loading
control. (D) pTRPV1 expression in hind paw skin lysates was quantitatively evaluated in RTX treated group including sham + pH 7.0 saline,
sham + pH 4.0 saline, TIIP + pH 7.0 saline and AS-TIIP by western blotting. The protein expression of pTRPV1 did not change in any of the
RTX treated groups compared to 7.0-treated sham groups (n = 6 in each group, 3 days after surgery and pH 4.0 injection). The pTRPV1 level
was normalized against corresponding total TRPV1. Data are presented here as a percentage change (%) compared to the sham control.
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AS-TIIP + vehicle and AS-TIIP + MRS2179 groups at
postoperative day 3 following daily injections of pH 4.0
saline (Figure 7). Vehicle and MRS2179 were repetitively
injected into the hind paw 30 min before pH 4.0 saline in-
jection. Acidic saline injection into the hind paw of TIIP
rats increased the expression of pTRPV1 (Figure 7, *P < 0.05Figure 5 The effect of AMG9810 and chelerythrine on
established thermal hyperalgesia (TH) in acidic saline injected
TIIP (AS-TIIP) rats. Effects of AMG9810 (a TRPV1 antagonist) and
chelerythrine (a PKC inhibitor) in established TH were evaluated at
day 3 post-surgery and pH 4.0 injection. (A) Intraplantar injection of
AMG9810 (3 and 10 nmol) was effective in reversing the established
TH in a dose dependent manner (n = 4, 4, 5 in each group). The analgesic
effect of AMG9810 was significant at 30 min and 1 h post-injection
(*p < 0.05, **p < 0.01 and ***p < 0.001 vs vehicle). (B) Intraplantar
injection of chelerythrine (10 and 30 nmol) dose dependently reversed
TH at the 1 and 3 h time point after injection in established TH
rats (n = 4, 6, 6 in each group, ***p < 0.001 vs vehicle).sham+ vehicle). More importantly, repeated i.pl treatment
with MRS2179 prior to the pH 4.0 saline injection
returned the expression of pTRPV1 to baseline levels
(Figure 7, # p < 0.05 vs AS-TIIP + vehicle). Quantitative
analysis of pTRPV1 expression was normalized against
corresponding total TRPV1 expression and calculated
as a percent (%) change with respect to the sham
group.
Discussion
It has been reported that tissue acidity corresponds to
the severity of hypoxic status, and the tissue acidic envir-
onment is a major factor for triggering ischemia related
pathological consequences [23,34,35]. In terms of pain
hypersensitivity, although low tissue pH at the ischemic
site has been considered a crucial factor in the develop-
ment of ischemic pain [8,14,36], the contribution of the
acidic environment to ischemia-induced thermal hyper-
sensitivity has not been delineated. The present study is
the first to demonstrate that under peripheral ischemic
conditions an increase in tissue acidity results in the de-
velopment of thermal hyperalgesia (TH). Here, we injected
pH 4.0 saline into the ischemic hind paw to evaluate how
an acidic tissue environment affected both thermal hyper-
sensitivity and TRPV1 activity under peripheral ischemic
condition. Since hypoxia inducible factor-1α (HIF-1α) is a
well-known indicator of hypoxia and carbonic anhydrase II
(CA II) has been reported to be a major indicator of pH
imbalance [23-29], we examine changes in these two fac-
tors in order to evaluate the degree of hypoxic injury and
tissue acidity. We observed that repetitive acidic saline in-
jection into the ischemic hind paw increased protein levels
of both hypoxia inducible factor-1α (HIF-1a) and carbonic
anhydrase II (CA II) in hind paw muscle (Figure 2). These
results indicated that the presence of an acidic tissue envir-
onment intensified the ischemia-associated insults to the
hind paw muscle tissue. Therefore, we postulate that injec-
tion of acidic saline into TIIP (AS-TIIP) rats represents a
model of the ischemic condition with severe tissue
acidosis.
Figure 6 The Effect of proton sensing ion channels and P2
receptors antagonists in the induction of thermal hyperalgesia
(TH) in acidic saline injected TIIP (AS-TIIP) rats. Graphs showing
the effects of Amiloride (a ASICs blocker), AMG9810 (a TRPV1
antagonist), TNP-ATP (a P2X antagonist) and MRS2179 (a P2Y1 antagonist)
on acidic injection-induced TH in TIIP rats. Each drug was repetitively
injected to the hind paw 30 min before pH 4.0 saline injections (D0-3
post-surgery). Amiloride (A, 30 and 100 nmol), AMG9810 (B, 3 and
10 nmol) and TNP-ATP (C, 100 and 300 nmol) given before pH 4.0 saline
injection did not prevent the development of TH (n = 7 in each group).
Conversely, repetitive treatment with MRS2179 (D, 100 and 300 nmol,
n = 4, 6, 5 in each group) effectively prevented the development
of TH in the AS-TIIP group (*p < 0.05, **p < 0.01 vs vehicle).
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sham rats did not affect thermal nociception (Figure 1),
these findings indicated that an increased acidic environ-
ment in the presence of other pro-algesic substances
under ischemic conditions could lead to the development
of TH. It has been reported that there is a synergism be-
tween low tissue pH conditions and pro-algesic sub-
stances in their effect on nociceptor excitation [37,38].
In the skin-nerve preparation, a strong interactionFigure 7 The effect of MRS2179 on phosphorylated TRPV1
(pTRPV1) expression in acidic saline injected TIIP (AS-TIIP) rats.
TRPV1 and pTRPV1 were detected by using western blots in the
hind paw skin of sham + vehicle, AS-TIIP + vehicle and AS-TIIP +
MRS2179 (n = 6 in each group, 3 days after surgery and pH 4.0 saline
injections). Vehicle and MRS2179 were repetitively injected into
the hind paw 30 min before pH 4.0 injection. The level of pTRPV1
expression significantly increased in AS-TIIP rats, and repeated
MRS2179 treatment decreased the ratio of pTRPV1 back to the
sham control level (*p < 0.05 vs sham + vehicle and # p < 0.05 vs
AS-TIIP + vehicle). The level of pTRPV1 expression was normalized
against the corresponding total expression of TRPV1. Quantitative
analysis of pTRPV1 was calculated as the percent (%) change with
respect to the sham group.
Kwon et al. Molecular Pain 2014, 10:2 Page 12 of 15
http://www.molecularpain.com/content/10/1/2between acidic pH and inflammatory mediators resulted
in an increased prevalence and magnitude of nociceptor
excitation [38]. This interaction was also shown in ex-
perimental tissue acidosis in human skin; e.g. the in-
jection of additional inflammatory mediators into the
acidic skin caused a more significant painful response
[37]. In a previous study we demonstrated that the
synergism between acidic saline and ATP produced a
significant facilitation of nociception (mechanical allo-
dynia and thermal hypersensitivity) in the normal rat
hind paw [20]. Accordingly, it is reasonable to hypo-
thesize that ATP may be one of the synergic factors
that contribute to acidic pH-mediated pain develop-
ment under ischemic conditions. Although we do not
measure the exact concentration of tissue ATP in TIIP
rats in the present study, it is well known that injured tis-
sues possess a high concentration of extracellular ATP es-
pecially during early induction phase [39,40]. In TIIP rats,
intraplantar injection of a P2 antagonist effectively allevi-
ated mechanical allodynia at day 3 after surgery [13].
Moreover, in the current study, we injected acidic saline
to the ischemic hind paw during this induction phase (D0
to D3), and observed increased thermal hypersensitivity.
These results imply that during the early induction phase
in which extracellular ATP concentration is elevated, in-
jection of acidic saline could effectively modulate P2Y1 re-
ceptors, which could contribute to the development of
increased thermal hypersensitivity.
Since previous studies have shown that P2Y1 and
TRPV1 receptors are located in the same population of
DRG neurons, we have examined the potential role of
TRPV1 receptors in this process by examining the effect
of injection of the specific TRPV1 antagonist AMG9810,
using two different approaches. First, in order to investi-
gate the potential involvement of TRPV1 in maintaining
TH, we performed a single intraplantar injection of the
selective TRPV1 antagoinst, AMG9810 at day 3. This
injection resulted in short-term alleviation of the
established TH (Figure 5A). Second, we performed re-
petitive intraplantar injection to further explore whether
each acidic stimulation directly affected TRPV1 or not.
AMG9810 were injected once a day (D0-D3 after surgery)
30 min before the acidic saline injection. Interestingly, this
pre-blockade of TRPV1 before acidic saline failed prevent
the induction of TH (Figure 6B). These results implied
that TRPV1 was a final gate for acid induced TH in TIIP
rats, but acid stimulation did not directly activate this
channel.
In the current study, we discovered that peripheral
P2Y1 receptors played a crucial role in acid induced TH,
based on the fact that repeated pre-injection of MRS2179,
a selective P2Y1 antagonist, effectively prevented the
acidic saline-induced TH in AS-TIIP rats (Figure 6D).
These results indicate that the acidic environment createdby pH 4.0 saline injection in the ischemic hind paw modu-
lates P2Y1 receptors, which in turn contribute to the de-
velopment of TH. On the other hand, TRPV1 receptors
do not appear to play a crucial role in the onset of TH in
this model. In addition, we also concluded that ASICs did
not contribute to thermal hypersensitivity in AS-TIIP rats
(Figure 6A). Previously, we reported that peripheral ASICs
were involved in maintaining ischemia-induced mechan-
ical allodynia in TIIP [13]. However, we were unable to in-
vestigate their contribution to TH in the present study,
since TIIP rats have normal heat sensitivity. In the current
study, we observed that low tissue pH in conjunction with
ischemia resulted in the development of TH in TIIP rats,
and ASICs were not involved in this ischemic thermal
hypersensitivity. On the other hand, ASICs did contribute
to mechanical allodynia in AS-TIIP rats (data not shown).
These results suggest that ASICs are a modality specific
contributor to mechanical allodynia in acid-induced
nociception, and there are several reports supporting
the specific role of ASICs in mechanical sensing and
hypersensitivity [20,41,42].
Although pH 4.0 is quite an extreme pH not often
seen even in pathophysiological conditions, several stud-
ies have examined the actual pH level in the plantar tis-
sue, and they demonstrated that the measured tissue pH
is considerably higher than solution pH level before in-
jection [21,41]. For example, Sluka et al. reported that
the repeated injection of pH 4.0 saline into gastrocne-
mius muscle lowered the muscle pH averaged 6.5 with
decreases in individual animals to pH 6 [21]. Therefore,
we have assumed that a single injection of pH 4.0 saline
would not extremely decrease the tissue pH, and further
considered that temporary acidic pH tissue condition in-
duced by pH 4.0 saline could mimic the pathophysio-
logical state shown in peripheral ischemic condition.
Collectively, the acidic environment is easily buffered by
physiological buffering systems [15,21,43], it may be dif-
ficult to activate TRPV1 receptors directly, since they
only respond under relatively low tissue pH (pH < 5–6)
[44-46]. Therefore, there is the strong possibility that the
interaction of the acidic environment and ATP indirectly
activate TRPV1 via P2Y1 receptors which up-regulates
intracellular signaling cascades, but this only occurs in
an ischemic environment in which tissue acidosis is
present.
It is well recognized that activation of TRPV1 recep-
tors contributes to peripheral sensitization, particularly
to heat stimuli. Pro-algesic substances such as protons,
ATP, bradykinin and prostaglandins sensitize nociceptors
either by directly modulating the sensitivity of mem-
brane receptors or by up-regulating intracellular signal-
ing cascades [5]. These signaling cascades include calcium
dependent protein kinase (PKC), cyclic AMP-dependent
protein kinase (PKA), and calcium-calmodulin dependent
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Since PKC dependent modulation of TRPV1 had been re-
ported to be the main pathway stimulated by inflamma-
tory mediators [5,47,48], an analysis of phosphorylated
TRPV1 that targeted S800 was performed in the present
study. Sham (pH 7.0 and 4.0), TIIP and AS-TIIP rats did
not show any alterations in TRPV1 expression (Figure 3A),
whereas the ratio of pTRPV1/TRPV1 was significantly ele-
vated in AS-TIIP rats (Figure 3B). Although it has been re-
ported that PKC dependent TRPV1 phosphorylation is
critical in the TRPV1 response to its agonist in vitro
[7,49,50], this is the first evidence that increased phos-
phorylation of TRPV1 in peripheral tissues directly corre-
lates with behavioral changes in vivo. Since TRPV1 is not
only located in peripheral nerve fibers, but also in the ker-
atinocytes distributed in the epidermis of the skin, our ini-
tial western blot data contain TRPV1 from both neuronal
and non-neuronal origins. Therefore, in attempt to eval-
uate the contribution of non-neuronal TRPV1 to the
up-regulation of the pTRPV1/TRPV1 ratio observed in
AS-TIIP rats, we gave resiniferatoxin (RTX) to several
groups of rats to destroy TRPV1 containing nerve fibers
and subsequently examined the changes in the ratio of
TRPV1 and pTRPV1 expression in paw lysates from
sham (pH 7.0 and 4.0) and TIIP (pH 7.0 and 4.0) rats.
Although TRPV1 was still present in hind paw lysates
from RTX treated rats, there were no significant changes
in the ratio of pTRPV1/TRPV1 in AS-TIIP rats (Figure 4D).
These results indicated that TRPV1 receptors associated
with keratinocytes or other non-neuronal sources did not
contribute to the increase in pTRPV1/TRPV1 ratios that
we observed in AS-TIIP animals. Collectively, these find-
ings suggest that the transitional rate of PKC dependent
phosphorylation of TRPV1 in peripheral nerve fibers is an
important factor in the development of heat hypersensitiv-
ity in chronic ischemic conditions.
P2Y1 receptors are Gq-coupled receptors located in
sensory neurons and these receptors have been implicated
in sensory transduction [30,51,52]. There are several re-
ports suggesting that there is a potential relationship be-
tween the P2Y1 and TRPV1 receptors that contributes to
increased pain hypersensitivity [7,30,53-55]. P2Y1 recep-
tors are located primarily in small diameter sensory neu-
rons, and thus it is perhaps not surprising that over 80%
of CGRP neuronal profiles in DRGs contain P2Y1 recep-
tors [53]. Interestingly Gerevich et al. demonstrated that
P2X3, TRPV1, and P2Y1 receptors were co-expressed in
~80% of small diameter DRG cells [54]. Furthermore,
there was direct evidence supporting a functional relation-
ship between P2Y1 and TRPV1 in DRG neurons; thus,
Yousuf et al. demonstrated that ADP-induced activation
of P2Y1 receptors facilitated capsaicin-induced currents,
and this facilitatory effect was prevented by protein kinase
C inhibition [55]. On the other hand, the relationship andinteraction between P2Y1 and TRPV1 receptors have not
yet been examined in vivo. In the current study, we exam-
ined the potential interaction between P2Y1 and TRPV1
receptors and demonstrated that this interaction resulted
in the development of a TH response in ischemic rats. As
indicated in Figure 7, we found that the creation of a more
acidic environment in the ischemic hind paw resulted in
the up-regulation of PKC-dependent pTRPV1 expression.
Moreover, pre-injection of the P2Y1 receptor antagonist,
MRS2179 significantly reduced this increase in pTRPV1
expression. Based on these results, we conclude that acti-
vation of P2Y1 receptors in an acidic environment modu-
lates TRPV1 activity (i.e. phosphorylation at the S800 site)
and ultimately causes the development of TH under per-
ipheral ischemic conditions. Although we do not delineate
the downstream individual molecular steps resulting from
activation of P2Y1 receptors in this study, it is feasible to
consider that activation of P2Y1 receptors can directly
phosphorylate TRPV1 through Gq/G11 related intracellu-
lar cascades. When agonists stimulate this type of recep-
tor, phosphatidylinositide-specific phospholipase C (PLC)
is activated and subsequently causes hydrolysis of PIP2 in
the plasma membrane. Inositol 1,4,5-triphosphate (IP3)
and diacylglycerol (DAG) are generated by PIP2 hydrolysis
resulting in the release of Ca2+ from intracellular stores
and subsequent activation of the protein kinase C (PKC)
pathway [56-58].
One of the questions resulting from the current study
relates to explaining the mechanism by which acidic tis-
sue conditions such as that associated with ischemia af-
fects P2Y1Rs. One possibility is that the lower pH found
in ischemic tissue changes the agonist affinity of the
P2Y1 receptor. Many reports have demonstrated that
extracellular protonation modulates the affinity of the
ATP binding site and enhances the agonist potency of
P2 receptors. For example, Li et al. demonstrated that
extracellular protons regulated the function of P2X re-
ceptors by modulating the affinity of the ATP binding
site [59]. Furthermore, extracellular protons have been
shown to significantly potentiate the agonist potency of
recombinant P2Y4 receptors, indicating the functional
potentiation of P2Y receptors by protons [60]. Further-
more, we should also consider the possibility that the
concentration of P2Y receptor agonists at the tissue site
might be changed by lower tissue pH. In this regard,
Dulla et al. reported that ATP hydrolysis to ADP and
adenosine (by ecto-nucleotidases) was closely link to the
PCO2 level and pH in hippocampal slices, and changes
in nucleotides levels ultimately modulated neuronal ex-
citability in the forebrain [61]. In addition, Sowa et al.
demonstrated that prostatic acid phosphatase (PAP),
which was expressed in nociceptive neurons and func-
tions as an ectonucleotidase, had pH-dependent ecto-
nucleotidase activity. At neutral pH, mPAP primarily
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lar conditions, mPAP could dephosphorylate all purine nu-
cleotides (AMP, ADP, ATP) [62]. Collectively, these reports
suggest that the acidic condition of the tissue can change
nucleotidase activity leading to increased dephosphoryla-
tion of ATP, which would result in an increase in ADP con-
centration and increased activatation of P2Y1 receptors.
Conclusions
In conclusion, the present study clearly demonstrates that
the presence of chronic ischemia in combination with in-
creased tissue acidity can alter TRPV1 receptor sensitivity,
not by a direct action of protons on the TRPV1 receptor,
but rather by an indirect action of ATP on TRPV1 recep-
tors that is mediated via a Gq-coupled P2Y1 receptor. Fur-
thermore, this activation of P2Y1 receptors by an increase
acidic tissue environment results in a PKC-dependent
TRPV1 phosphorylation, which ultimately contributes to
the development of thermal hyperalgesia. Thus, this study
suggests a novel peripheral mechanism that may underlie
the development of thermal hyperalgesia in chronic ische-
mic patients with severe acidosis.
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